MCLA-117 in Acute Myelogenous Leukemia

Summary

This is a First-in-Human, single arm, open-label, multi-national study designed to determine the safety, tolerability and preliminary efficacy of MCLA 117.

Timeline

Start

2016-04

Primary completion

2021-05-11

Completion

2021-05-11

Outcome

Outcome not reported

Stopped (Business): “strategic considerations”

Drugs

Indications